Le Lézard
Classified in: Covid-19 virus
Subject: Personnel

Emory Board of Trustees Names Gregory L. Fenves as 21st President


The Emory University Board of Trustees announced today that Gregory L. Fenves, president of The University of Texas (UT) at Austin, has been elected as the 21st president of Emory University by a unanimous vote of the board. Fenves will assume office on August 1, 2020.

Fenves succeeds Claire E. Sterk, who announced her retirement in November 2019 after serving as Emory's president since 2016.

"We are tremendously excited about the appointment of Greg Fenves, a world-class educator and brilliant leader," says Bob Goddard, chair of Emory's Board of Trustees and of the Presidential Selection Committee. "We wanted someone with deep experience leading a major research university and a stellar record of scholarship. We also sought an inspirational leader and a person of impeccable character. Greg Fenves embodies all that we hoped to find.

"We are also acutely aware of the impact that COVID-19 is having on our universities and our communities. Greg and I agree that, out of respect for all of those who are working hard to combat the virus and care for their families, we only want to make a brief introduction today. When the clouds lift and we are all able to return to our normal routines, we will plan a more complete welcome for Greg and his family."

Fenves' unanimous election by the board took place after the Presidential Selection Committee led an intensive international search that included more than 40 listening sessions throughout the Emory community and confidential interviews with diverse and prominent candidates.

"I am deeply honored to be named president of Emory University by the Board of Trustees," Fenves says. "It has been a privilege to lead UT Austin, which I believe is among America's best public institutions of higher education. I am excited to join one of the country's finest research universities. Optimistic about Emory's future, I am convinced that working together as one university, we will move Emory from the outstanding institution it is today to one of eminence.

"But today, our universities face extraordinary challenges. In Atlanta and Austin, as well as across the country, courageous health professionals and brilliant scientists are caring for the stricken and searching for a vaccine, while our faculty are educating students at a distance. I stand with them, and we must continue with the immediate job at hand. Accordingly, for the next few months, I will devote my time and energy to leading UT Austin through this crisis. My wife, Carmel, and I look forward to the day when we can begin the next phase of our lives at Emory."

Goddard said the selection committee was impressed with the enormous impact Fenves had on UT Austin during his 12 years, first as dean of the engineering school, then as provost and finally as president. Under Fenves' leadership, UT Austin has prioritized its outstanding faculty, cross-disciplinary research and student success, and launched the first new medical school at a top-tier research university in nearly 50 years. Fenves has made diversity and inclusion a priority, successfully leading UT Austin to the U.S. Supreme Court to defend the educational benefits of diversity in higher education in the landmark Fisher case. And he has been deeply engaged with UT Austin students throughout his presidency.

"The next decade will be critically important in the evolution of Emory as one of the nation's eminent research universities," Goddard says. "The board believes with Greg Fenves as our next president, we will have the key components to make significant advancements as an institution. And we are proud of what he has seen in Emory and that a university leader of such stature is attracted to the opportunities at Emory."

Fenves is married to Carmel Martinez Fenves, a textile artist and former small business owner. They have two adult daughters, a son-in-law and one granddaughter, all of whom live in Austin.

Full story at news.emory.edu>>


These press releases may also interest you

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

18 avr 2024
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...



News published on and distributed by: